High quality whole transcriptome RNA-sequencing from challenging clinical samples

Affiches Apr 21, 2026

Séquençage

April 21, 2026

Études de cas

Jun 15, 2026

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

Poster: analytical validation of high-resolution ctDNA profiling with TSO500 v2.0.

Affiches

Apr 20, 2026

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Brochure

Apr 15, 2026

Genomic Assay List

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

High quality whole transcriptome RNA-sequencing from challenging clinical samples

Featured Resources

Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Genomic Assay List

One global CRO for your whole therapeutic development journey